WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 51'6901 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 44'0891 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 35'525  35'182  34'838  34'487  34'126  30'697  27'658  24'511 
Births 400  396  391  386  381  334  387  362 
Surviving infants 399  394  389  384  379  332  385  358 
Pop. less than 5 years 2'012  1'991  1'967  1'932  1'881  1'792  1'929  1'792 
Pop. less than 15 years 5'848  5'785  5'728  5'675  5'621  5'885  5'727  5'581 
Female 15-49 years 8'220  8'243  8'268  8'289  8'302  7'972  7'470  6'540 

Number of reported case

(Click for retrospective incidence data for Canada)
Diphtheria 55 
Japanese encephalitis
Measles 418  82  10  759  99  206  1'033  13'864 
Mumps 40  92  54  282  799  88 
Pertussis 1'527  1'261  4'845  676  759  4'054  8'030  2'873 
Polio*
Rubella 12  28 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Canada)
Vaccine year result method % card seen                                                
BCG         
DTP1          99 
DTP3          96  95  96  77 
DTP4         
IPV1         
HepB_BD         
HepB3          75  70  70 
Hib3          96  95  96  77 
JapEnc         
MCV1          95  98  95  93 
MCV2          94 
PCV1          98  98  98 
PCV3          77  97  77 
Pol3          96  99  96  83 
Rota1         
Rota_last         
Rubella1          95  98  98  93 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Canada)
DTP1 98  98  95  98  98  95  96 
DTP3 96  96  95  96  96  89  88 
HepB3 75  75  70  70  56 
HepB_BD
Hib3 96  96  95  96  96  88 
MCV1 95  95  98  95  95  96  89 
MCV2 94  94  94 
PCV3 97  97  97  77  67 
Pol3 96  96  99  96  95  88  88 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG BCG-Infants & children belonging to groups with high rates of infection
DTaPHibHepIPV 2, 4, 6 months;
DTaPHibIPV 2, 4, 6, 18 months;
DTaPIPV 4-6 years; Yes
HPV 1st contact; +2, +6 months; Yes
HepA high risk groups
HepB Early infancy (3 doses) or pre-teen (2-3 doses)
Influenza > 6 months; > 18 years; Yes
MMR 12, 18 months; or 4-6 years; Yes
MenC_conj Yes Infancy (1-4 doses) and pre-teen (1 dose)
Pneumo_conj 2, 4, 6, 12-16 months; Yes
Pneumo_ps >=65 years; Yes
Rotavirus 2, 4, 6 months; Yes
Td every 10 years for those who have completed primary series
Tdap 14-16 years; Yes
Varicella 12 months; 18 months or 4-6 years; Yes Recommended for susceptible older children, adolescents and adults

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR   Yes  Yes  Yes    Yes  Yes 
What years does the MYP cover? number       2004-2009       
Nº of districts with microplans that include activities to raise immunization coverage number   13  13  13    13   

System performance

Total Nº districts in country number           13  13 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100%          
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND   Yes  Yes         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR   Yes           

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%             100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR   Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.